Two Sigma Investments
ALZN icon

Two Sigma Investments’s Alzamend Neuro ALZN Stock Holding History

Two Sigma Investments’s Portfolio ALZN Stock Details ALZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-14
Closed -$10.9K – 2938
2022
Q4 		$10.9K Buy
+14
New +$20.3K ﹤0.01% 2727
2021
Q4 		– Sell
-128
Closed -$533K – 4228
2021
Q3 		$533K Buy
+128
New +$703K ﹤0.01% 3197

Other funds holding ALZN

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Two Sigma Investments's ALZN Position: Q1 2023 in Review

Two Sigma Investments sold out of Alzamend Neuro (ALZN) in Q1 2023, closing a stake of 14 shares — an estimated $10.9K sold.

Two Sigma Investments first reported a position in ALZN in Q3 2021 and held it in 2 quarters. The position peaked at $533K in Q3 2021. 24 funds tracked by Wall St. Rank hold ALZN as of Q1 2023.

  • Two Sigma Investments reported no remaining Alzamend Neuro position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Investments sold 14 Alzamend Neuro shares in Q1 2023, an estimated $10.9K.
  • Two Sigma Investments first reported a position in Alzamend Neuro in Q3 2021 and held it in 2 quarters.
  • Two Sigma Investments's Alzamend Neuro position peaked at $533K in Q3 2021.
  • 24 funds tracked by Wall St. Rank held Alzamend Neuro as of Q1 2023.

Based on Two Sigma Investments's 13F filing for Q1 2023, filed 15 May 2023.